These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 345961)
61. [Increased effectiveness of antibiotic therapy with adaptogens in dysentery and Proteus infection in children]. Vereshchagin IA; Geskina OD; Bukhteeva ER Antibiotiki; 1982 Jan; 27(1):65-9. PubMed ID: 7036851 [TBL] [Abstract][Full Text] [Related]
62. [Prolongation of the effect of immunostimulators as means of increasing resistance to causative agents of infection]. Sviridov LP; Stepanov AV Antibiot Khimioter; 1990 May; 35(5):32-5. PubMed ID: 2383152 [TBL] [Abstract][Full Text] [Related]
63. [Changes in the factors of nonspecific protection of the body during treatment of inflammatory diseases of the maxillofacial area in elderly persons using prodigiozan]. Zakson ML; Bordonos VG Stomatologiia (Mosk); 1987; 66(6):9-11. PubMed ID: 3481503 [No Abstract] [Full Text] [Related]
64. [Effect of prodigiozan on the phagocytic activity of the leukocytes in melioidosis intoxication]. Morozova EIa Antibiotiki; 1977; 22(2):165-8. PubMed ID: 324384 [TBL] [Abstract][Full Text] [Related]
65. [Effect of mytilan--a polysaccharide from Crenomytilus grayanus--on local suppurative processes]. Krylova NF; Ovodova RG; Besednova NN; Glazkova VE; Molchanova VI Antibiot Med Biotekhnol; 1985 Aug; 30(8):600-4. PubMed ID: 4062278 [TBL] [Abstract][Full Text] [Related]
66. [Immunomodulating therapy of adjuvant disease in rats using cyclophosphamide in combination with prodigiozan--its effect on anti-infectious resistance]. Sibiriak SV; Lazareva DN; Khaĭbullina SF Antibiot Khimioter; 1988 Jul; 33(7):532-5. PubMed ID: 3056303 [TBL] [Abstract][Full Text] [Related]
68. Cytotoxicity of leukocytes from normal and Shigella-susceptible (opium-treated) guinea pigs against virulent Shigella sonnei. Morgan DR; DuPont HL; Wood LV; Kohl S Infect Immun; 1984 Oct; 46(1):22-4. PubMed ID: 6384044 [TBL] [Abstract][Full Text] [Related]
69. [Some problems of the mechanism of artificial acquired immunity]. GINZBURG-KALININA SI Zh Mikrobiol Epidemiol Immunobiol; 1961 Sep; 32():52-8. PubMed ID: 13898786 [No Abstract] [Full Text] [Related]
70. [Nonspecific stimulation of the body's natural resistance to infection with prodigiozan]. Bukharin OV Zh Mikrobiol Epidemiol Immunobiol; 1966 Sep; 43(9):54-8. PubMed ID: 4981249 [No Abstract] [Full Text] [Related]
71. [Experience in using prodigiozan in the overall treatment of suppurative surgical diseases in children]. Zhukov MD; Geĭn VV Klin Khir (1962); 1979 Jun; (6):38-40. PubMed ID: 379414 [No Abstract] [Full Text] [Related]
72. General considerations in the management of typhoid fever and dysentery. Gilman RH Scand J Gastroenterol Suppl; 1989; 169():11-8. PubMed ID: 2694338 [TBL] [Abstract][Full Text] [Related]
73. [Indices of peripheral blood lymphocyte blast and macrophagal transformation in typhoid and dysentery in the presence of a bacteriophage homologous to the type of causative agent]. Belov GF; Kolesnikova AF; Belova LG; Sem'ianova NS; Shevelev VI Zh Mikrobiol Epidemiol Immunobiol; 1978 Sep; (9):133. PubMed ID: 371298 [No Abstract] [Full Text] [Related]
74. [Effect of bacterial lipopolysaccharide preparations on hemopoiesis in depressed hemopoiesis induced by ionizing radiation]. Baranov MN; Golubeva LA; Martirosov KS; Petkevich NV Gematol Transfuziol; 1986 Oct; 31(10):30-3. PubMed ID: 3792807 [No Abstract] [Full Text] [Related]
75. [Effect of terrilytin on the activity of nonspecific resistance factors during immunization with staphylococcal anatoxin and staphylococcal infection]. Bel'skiĭ VV; Zakarian LM; Prokopenko LG; Chalyĭ GA Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):90-5. PubMed ID: 2458002 [TBL] [Abstract][Full Text] [Related]
76. Antitumor activity of polysaccharides from Serratia marcescens. Ikekawa T; Ikeda Y; Fukuoka F Gan; 1975 Jun; 66(3):317-8. PubMed ID: 1102378 [TBL] [Abstract][Full Text] [Related]
77. [Combined use of mytilan and gentamycin in experimental infections ]. Krylova NV; Lobuseva AN; Besednova NN Antibiot Khimioter; 1988 Jan; 33(1):61-3. PubMed ID: 3288147 [TBL] [Abstract][Full Text] [Related]
78. [Experience in the use of agar immunoelectrophoresis for the determination of the role of individual blood protein fractions in the formation of antibodies in typhoid and dysentery]. Ivanov AI Zh Mikrobiol Epidemiol Immunobiol; 1965 Apr; 42(4):111-2. PubMed ID: 5887746 [No Abstract] [Full Text] [Related]
79. [Symposium on bacterial infections in the cell]. Kusano S; Iwata K; Yamaguchi H; Kanda Y; Notsu Y Nihon Saikingaku Zasshi; 1971 Jun; 26(4):130-6. PubMed ID: 4996059 [No Abstract] [Full Text] [Related]
80. [Clinical evaluation of kanamycin in the last 10 years]. Donomae I Nihon Ishikai Zasshi; 1967 Dec; 58(12):1397-400. PubMed ID: 4875598 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]